1887

Abstract

Introduction:

Globally, extra-intestinal pathogenic are one of the predominant causative agents of bacteraemia.

Case presentation:

This case report outlines a presentation of community-acquired pyelonephritis and secondary bloodstream infection in an 81-year-old man. Laboratory investigations revealed that the causative isolate was a multi-drug-resistant of a novel multi-locus sequence type. This sequence type (ST) was designated ST-458 and was most closely related to the globally prevalent ST-131 lineage.

Conclusion:

This is the first report of a novel ST, ST-458, which caused pyelonephritis and bacteraemia.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.005061
2016-09-01
2020-04-08
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/3/5/jmmcr005061.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.005061&mimeType=html&fmt=ahah

References

  1. Al-Hasan M. N., Lahr B. D., Eckel-Passow J. E., Baddour L. M.. 2009; Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998-2007. J Antimicrob Chemother64:169–174[CrossRef]
    [Google Scholar]
  2. Alhashash F., Weston V., Diggle M., McNally A.. 2013; Multidrug-resistant Escherichia coli bacteremia. Emerg Infect Dis19:1699–1701 [CrossRef][PubMed]
    [Google Scholar]
  3. de Kraker M. E., Jarlier V., Monen J. C., Heuer O. E., van de Sande N., Grundmann H.. 2013; The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect19:860–868 [CrossRef][PubMed]
    [Google Scholar]
  4. Guyer D. M., Radulovic S., Jones F. E., Mobley H. L.. 2002; Sat, the secreted autotransporter toxin of uropathogenic Escherichia coli, is a vacuolating cytotoxin for bladder and kidney epithelial cells. Infect Immun70:4539–4546 [CrossRef][PubMed]
    [Google Scholar]
  5. Jackson L. A., Benson P., Neuzil K. M., Grandjean M., Marino J. L.. 2005; Burden of community-onset Escherichia coli bacteremia in seniors. J Infect Dis191:1523–1529 [CrossRef][PubMed]
    [Google Scholar]
  6. Johnson J. R.. 1991; Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev4:80–128 [CrossRef][PubMed]
    [Google Scholar]
  7. Lloyd A. L., Rasko D. A., Mobley H. L.. 2007; Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli. J Bacteriol189:3532–3546 [CrossRef][PubMed]
    [Google Scholar]
  8. Miajlovic H., Smith S. G.. 2014; Bacterial self-defence: how Escherichia coli evades serum killing. FEMS Microbiol Lett354:1–9 [CrossRef][PubMed]
    [Google Scholar]
  9. Miajlovic H., Cooke N. M., Moran G. P., Rogers T. R., Smith S. G.. 2014; Response of extraintestinal pathogenic Escherichia coli to human serum reveals a protective role for Rcs-regulated exopolysaccharide colanic acid. Infect Immun82:298–305 [CrossRef][PubMed]
    [Google Scholar]
  10. Miajlovic H., Aogáin M. M., Collins C. J., Rogers T. R., Smith S. G.. 2016; Characterization of Escherichia coli bloodstream isolates associated with mortality. J Med Microbiol65:71–79 [CrossRef][PubMed]
    [Google Scholar]
  11. Mulvey M. A., Schilling J. D., Martinez J. J., Hultgren S. J.. 2000; Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A97:8829–8835 [CrossRef][PubMed]
    [Google Scholar]
  12. Nicolas-Chanoine M. H., Bertrand X., Madec J. Y.. 2014; Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev27:543–574 [CrossRef][PubMed]
    [Google Scholar]
  13. Nipič D., Podlesek Z., Budič M., Črnigoj M., Žgur-Bertok D.. 2013; Escherichia coli uropathogenic-specific protein, Usp, is a bacteriocin-like genotoxin. J Infect Dis208:1545–1552 [CrossRef][PubMed]
    [Google Scholar]
  14. Smith S. N., Hagan E. C., Lane M. C., Mobley H. L.. 2010; Dissemination and systemic colonization of uropathogenic Escherichia coli in a murine model of bacteremia. MBio1:e0026210 [CrossRef][PubMed]
    [Google Scholar]
  15. Stoesser N., Sheppard A. E., Pankhurst L., De Maio N., Moore C. E., Sebra R., Turner P., Anson L. W., Kasarskis A. et al. 2016; Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131. MBio7:e02162 [CrossRef][PubMed]
    [Google Scholar]
  16. Subashchandrabose S., Smith S. N., Spurbeck R. R., Kole M. M., Mobley H. L.. 2013; Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog9:e1003788 [CrossRef][PubMed]
    [Google Scholar]
  17. Ulett G. C., Valle J., Beloin C., Sherlock O., Ghigo J. M., Schembri M. A.. 2007; Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract. Infect Immun75:3233–3244 [CrossRef][PubMed]
    [Google Scholar]
  18. Walsh P., Carroll J., Sleator R. D.. 2013; Accelerating in silico research with workflows: a lesson in Simplicity. Comput Biol Med43:2028–2035 [CrossRef][PubMed]
    [Google Scholar]
  19. Weissman S. J., Johnson J. R., Tchesnokova V., Billig M., Dykhuizen D., Riddell K., Rogers P., Qin X., Butler-Wu S. et al. 2012; High-resolution two-locus clonal typing of extraintestinal pathogenic Escherichia coli. Appl Environ Microbiol78:1353–1360 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.005061
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.005061
Loading

Data & Media loading...

Most cited this month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error